Transcranial direct current stimulation in adolescent and adult Rasmussen's encephalitis.

Rasmussen's encephalitis is a rare, progressive inflammatory disease that typically affects one cerebral hemisphere and causes intractable partial-onset seizures. Currently, the only effective therapy is hemispherectomy; however, this procedure is associated with irreversible neurological deficits. Novel therapeutic approaches to this condition are therefore necessary. One possible option that has not yet been extensively studied is electrical cathodal transcranial direct current stimulation (cTDCS). We describe the cases of two patients with atypical-onset Rasmussen's encephalitis who underwent cTDCS at 1- and 2-mA intensity for 60 minutes in four sessions (on days 0, 7, 30, and 60). No complications were recorded during their therapy. At follow-up evaluations 6 and 12 months later, one patient had a significant reduction in seizure frequency and one was seizure free. Additionally, both patients had improved levels of alertness and language. This is the first time that cTDCS has been applied in serial sessions to treat Rasmussen's encephalitis to avoid or delay surgical treatment.

EEG Findings and Releases From Hospital for Patients With Anti-NMDA Receptor Encephalitis.

PURPOSE: Anti-N-methyl-D-aspartate receptor encephalitis is produced by an autoimmune reaction against macromolecular structures that form ionotropic receptors for glutamic acid NR2A and NR2B subunits. Other important findings are the multiple clinical and paraclinical manifestations, among which the EEG stands out. We characterized EEG patterns and their association with functional disability and hospitalization time in patients with anti-N-methyl-D-aspartate receptor encephalitis admitted in our center. METHODS: We performed a retrospective cohort study that included patients with anti-N-methyl-D-aspartate receptor encephalitis. We recorded the clinical and sociodemographic characteristics and initial scalp EEG data. Functional disability was evaluated at admission and follow-up using the modified Rankin scale. RESULTS: Forty-five patients aged 15 to 80 years were included. An abnormal EEG was reported in 92.5% of patients. We identified six EEG patterns. The mean hospitalization time was 3.2 (±2.4) months. The higher modified Rankin scale at admission and the absence of parietal or temporal epileptiform activity were associated with more prolonged hospitalization, hazard ratio of 0.338 for each modified Rankin scale level (95% confidence interval 0.174-0.658, P = 0.001), 14.5, P = 0.017, and hazard ratio of 5.6, P = 0.009, respectively. CONCLUSIONS: EEGs are frequently abnormal in patients with anti-N-methyl-D-aspartate receptor encephalitis. The lower modified Rankin scale at admission and the absence of some focal epileptiform activity may be associated with shorter hospitalizations.

Miller fisher syndrome: 10 years' experience in a third-level center.

INTRODUCTION: There are few studies regarding the clinical characteristics of Miller Fisher syndrome (MFS) in the Latin-American population. METHODS: A retrospective analysis was made of the clinical characteristics, neurophysiology, treatment and prognosis of MFS patients between 1995 and 2005. RESULTS: Nineteen MFS cases were documented, 12 of which did not receive immunosuppressive therapy. In both groups, the mean age was 36 years, 84% were male; onset in spring and fall was also predominant (73%), and antecedents of respiratory disease were found (79%). The mean duration of infectious symptoms was 7 days (1-11 days), and the mean interval between the onset of the infection and neurological symptoms was 7 days (1-30 days). The principal sign of onset was diplopia (63%). The mean delay between the onset of neurological symptoms and the beginning of recovery from ataxia, ophthalmoplegia and areflexia was 10 (1-30 days), 11 (1-30 days) and 14 (4-45 days) days, respectively, and the mean delay of the disappearance of ataxia, ophthalmoplegia and areflexia was 35 (10-121 days), 93 (18-244 days) and 64 (10-650 days) days, respectively. There was no significant difference between the group that received immunosuppression and the one that did not. DISCUSSION: The natural course of MSF is characterized by excellent recovery; there were no differences between the two groups.

Transcranial Direct Current Stimulation in Epilepsy.

BACKGROUND: Transcranial direct current stimulation (tDCS) is an emerging non-invasive neuromodulation therapy in epilepsy with conflicting results in terms of efficacy and safety. OBJECTIVE: Review the literature about the efficacy and safety of tDCS in epilepsy in humans and animals. METHODS: We searched studies in PubMed, MedLine, Scopus, Web of Science and Google Scholar (January 1969 to October 2013) using the keywords 'transcranial direct current stimulation' or 'tDCS' or 'brain polarization' or 'galvanic stimulation' and 'epilepsy' in animals and humans. Original articles that reported tDCS safety and efficacy in epileptic animals or humans were included. Four review authors independently selected the studies, extracted data and assessed the methodological quality of the studies using the recommendations of the Cochrane Handbook for Systematic Reviews of Interventions, PRISMA guidelines and Jadad Scale. A meta-analysis was not possible due to methodological, clinical and statistical heterogeneity of included studies. RESULTS: We analyzed 9 articles with different methodologies (3 animals/6 humans) with a total of 174 stimulated individuals; 109 animals and 65 humans. In vivo and in vitro animal studies showed that direct current stimulation can successfully induce suppression of epileptiform activity without neurological injury and 4/6 (67%) clinical studies showed an effective decrease in epileptic seizures and 5/6 (83%) reduction of inter-ictal epileptiform activity. All patients tolerated tDCS well. CONCLUSIONS: tDCS trials have demonstrated preliminary safety and efficacy in animals and patients with epilepsy. Further larger studies are needed to define the best stimulation protocols and long-term follow-up.

Intraoperative monitoring of the abducens nerve in extended endonasal endoscopic approach: a pilot study technical report.

BACKGROUND: To determine the reliability and usefulness of intraoperative monitoring of the abducens nerve during extended endonasal endoscopic skull base tumor resection. METHODS: We performed abducens nerve intraoperative monitoring in 8 patients with giant clival lesions recording with needle electrodes sutured directly into the lateral rectus muscles of the eye to evaluate spontaneous electromyographic activity and triggered responses following stimulation of the abducens nerves. RESULTS: A total of 16 abducens nerves were successfully recorded during endoscopic endonasal skull base surgeries. Neurotonic discharges were seen in two patients (12% [2/16] abducens nerves). Compound muscle action potentials of the abducens nerves were evoked with 0.1-4mA and maintained without changes during the neurosurgical procedures. No patient had new neurological deficits or ophthalmological complications post-surgery. CONCLUSIONS: Intraoperative monitoring of the abducens nerve during the extended endonasal endoscopic approach to skull base tumors appears to be a safe method with the potential to prevent neural injury through the evaluation of neurotonic discharges and triggered responses.

Periodic epileptiform discharges in mesial temporal lobe epilepsy with hippocampal sclerosis.

PURPOSE: Periodic epileptiform discharges (PEDs) are an uncommon, abnormal EEG pattern seen usually in patients with acute diseases and less frequently in chronic conditions, such as mesial temporal lobe epilepsy (mTLE). Evaluate the clinical histories, neuroimaging findings, and serial electrophysiological studies prior to the appearance of PEDs in patients with mTLE secondary to hippocampal sclerosis (HS). METHODS: We searched 19, 375 EEGs (2006-2012) for the presence of PEDs secondary to mTLE due to HS. RESULTS: 12 patients were included. The patients with PEDs had a high prevalence of psychiatric comorbilities, including major depression (50%), interictal psychosis (16%) and dementia (8%). All of the patients had intractable epilepsy with similar clinical findings. We observed a sequential neurophysiological worsening of the EEG patterns prior to the appearance of PEDs. Five patients with PEDs underwent epilepsy surgery and four were seizure free at follow-up 15 (±9) months. CONCLUSIONS: PEDs are rare in patients with mTLE and HS and their presence in these cases could reflect clinical severity and neurophysiologic worsening, clinically manifested by intractable epilepsy and severe psychiatric comorbidities. The presence of PEDs in EEGs of patients with mTLE, however, was not associated with poor postsurgical seizure-freedom.

The prognostic role of electrocorticography in tailored temporal lobe surgery.

UNLABELLED: Intraoperative electrocorticography (ECoG) has been in clinical use for many decades, yet the validity of this procedure in guiding resective surgery for temporal lobe epilepsy (TLE) is still uncertain, especially in tailored temporal lobectomies in cases of TLE with hippocampal sclerosis. METHODOLOGY: Using a case-control design combined with descriptive and comparative analyses we retrospectively evaluated two groups of patients: patients (n=20) who had tailored temporal lobectomies guided by intraoperative ECoG and patients (n=19) who had standard temporal lobectomies without ECoG. Clinical and neuroimaging data, pre- and post-resection ECoG recordings, and seizure-free outcomes were reviewed. RESULTS: Of the 20 patients who underwent epilepsy surgery guided by ECoG, pre-resection ECoG studies found spikes both in mesial temporal lobe (MTL) and lateral temporal lobe (LTL) in 10 patients, and restricted to the LTL or MTL in 7 and 3 patients respectively. Postsurgical ECoG captured residual epileptiform activity in only 3 patients, all of whom had MTL and LTL spikes prior to surgery. Postsurgical follow-up at 16.3 (±6.7) months found 15 (75%) patients were seizure free (1A), while 5 (25%) had other outcomes. Analysis found no difference in the proportion of seizure-free outcomes between patients with residual epileptiform activity compared to those without residual epileptiform activity, or between patients who had a tailored resection guided by ECoG and patients who had standard resections without ECoG monitoring. CONCLUSION: The patients who underwent tailored temporal lobe epilepsy surgery guided by ECoG had similar outcome compared with the patients with epilepsy surgery not guided by ECoG.